BIOMAT Database Logo BIOMAT Database Logo

Plasma adrenomedullin levels, body fluid status, and end-stage renal failure. 1998

M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Department of Nephrology, Ludwig Maximilians University, Munich, Germany.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D053607 Adrenomedullin A 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion. ADM (1-52),ADM(1-52),Adrenomedullin (1-52),PAMP(1-20)NH2,Proadrenomedullin (1-20),Proadrenomedullin N-Terminal 20 Peptide,Proadrenomedullin N Terminal 20 Peptide

Related Publications

M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Body image in end-stage renal failure.
January 1992, British journal of nursing (Mark Allen Publishing),
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
January 1993, Nephron,
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Mineral status in children with end stage renal failure.
November 1986, The International journal of artificial organs,
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Increased levels of plasma 8-EPI-PGF2α in patients with end stage renal failure.
August 1997, Redox report : communications in free radical research,
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Plasma volumes, noradrenaline levels and renin activity during posture changes in end-stage renal failure.
April 1984, Clinical physiology (Oxford, England),
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
End-stage renal failure.
October 1971, Nursing times,
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
End-stage renal failure.
November 1978, Postgraduate medicine,
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
End stage renal failure.
January 1988, Nursing,
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study.
February 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Toepfer, and S M Lang, and G Hartmann, and T Sitter, and H Schiffl
Body composition of children with chronic and end-stage renal failure.
November 2007, Journal of paediatrics and child health,
Copied contents to your clipboard!